These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23065126)

  • 21. Risk perception, changing social context, and norms prevent transition to regular injection among people who smoke heroin.
    Harris J; Shorter GW; Davidson G; Best P
    Drug Alcohol Depend; 2020 Mar; 208():107878. PubMed ID: 32014646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.
    Wejnert C; Hess KL; Hall HI; Van Handel M; Hayes D; Fulton P; An Q; Koenig LJ; Prejean J; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1336-1342. PubMed ID: 27906906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated transition to injection among male heroin initiates in Hanoi, Vietnam: implications for early harm reduction interventions.
    Clatts MC; Goldsamt LA; Giang le M; Colón-López V
    J Community Health; 2011 Dec; 36(6):999-1003. PubMed ID: 21452028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.
    Mateu-Gelabert P; Harris S; Berbesi D; Segura Cardona ÁM; Montoya Vélez LP; Mejía Motta IE; Jessell L; Guarino H; Friedman SR
    Subst Use Misuse; 2016 Jan; 51(2):230-40. PubMed ID: 26800352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.
    Brugal MT; Pulido J; Toro C; de la Fuente L; Bravo MJ; Ballesta R; Soriano V; Barrio G; Vallejo F; Domingo-Salvany A; Castellano Y;
    Eur Addict Res; 2009; 15(3):171-8. PubMed ID: 19506378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.
    Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H
    J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV risk factors among injecting drug users in five US cities.
    Battjes RJ; Pickens RW; Haverkos HW; Sloboda Z
    AIDS; 1994 May; 8(5):681-7. PubMed ID: 8060548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
    Fu TC; Westergaard RP; Lau B; Celentano DD; Vlahov D; Mehta SH; Kirk GD
    AIDS; 2012 Nov; 26(18):2383-91. PubMed ID: 23079804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining racial/ethnic disparities in sexually transmitted diseases among recent heroin-using and cocaine-using women.
    Cavanaugh CE; Floyd LJ; Penniman TV; Hulbert A; Gaydos C; Latimer WW
    J Womens Health (Larchmt); 2011 Feb; 20(2):197-205. PubMed ID: 21314446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.
    Burnett JC; Broz D; Spiller MW; Wejnert C; Paz-Bailey G
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(1):23-28. PubMed ID: 29324726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injection and non-injection drug use and infectious disease in Baltimore City: differences by race.
    Keen L; Khan M; Clifford L; Harrell PT; Latimer WW
    Addict Behav; 2014 Sep; 39(9):1325-8. PubMed ID: 24837755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention.
    Syvertsen JL; Agot K; Ohaga S; Strathdee SA; Camlin CS; Omanga E; Odonde P; Rota G; Akoth K; Peng J; Wagner KD
    Drug Alcohol Depend; 2015 Jun; 151():262-6. PubMed ID: 25861945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial/ethnic differences in the rates and correlates of HIV risk behaviors among drug abusers.
    Brooks AJ; Lokhnygina Y; Meade CS; Potter JS; Calsyn DA; Greenfield SF
    Am J Addict; 2013; 22(2):136-47. PubMed ID: 23414499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.
    Meandzija B; O'Connor PG; Fitzgerald B; Rounsaville BJ; Kosten TR
    Drug Alcohol Depend; 1994 Oct; 36(2):109-13. PubMed ID: 7851277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection drug users in the United States, 1979-2002: an aging population.
    Armstrong GL
    Arch Intern Med; 2007 Jan; 167(2):166-73. PubMed ID: 17242318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Condom use among unmarried students in a Hispanic-serving university.
    Kim S; De La Rosa M; Trepka MJ; Kelley M
    AIDS Educ Prev; 2007 Oct; 19(5):448-61. PubMed ID: 17967114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of high-risk sexual behaviors for human immunodeficiency virus infection among Iranian drug abusers.
    Keshtkar A; Majdzadeh R; Nedjat S; Gholipour M; Badakhshan A; Qorbani M; Vakili M; Salari H
    J Addict Med; 2012 Jun; 6(2):153-8. PubMed ID: 22475984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.
    Mirzazadeh A; Evans JL; Hahn JA; Jain J; Briceno A; Shiboski S; Lum PJ; Bentsen C; Davis G; Shriver K; Dimapasoc M; Stone M; Busch MP; Page K
    AIDS Behav; 2018 Apr; 22(4):1383-1394. PubMed ID: 29168067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
    Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.